Superiority of total white blood cell count over other leukocyte differentials for predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome.
Leukocytes have been found to be the predictor of outcome following acute coronary syndrome (ACS). We sought to determine the relationship between leukocyte differentials and developing major adverse cardiac events (MACE) in patients with non-ST elevation ACS (NSTE-ACS). A total of 490 consecutive patients were enrolled, and MACE incidence was evaluated at long-term follow-up period. Total white blood cell (WBC) was higher in subjects occurring MACE. Moreover, elevated total WBC, ≥7.5 × 10(3)/µL, independently predicted MACE. Elevated admission total WBC can predict long-term MACE in NSTE-ACS patients better than other differentials.